Invention Grant
US07888320B2 Composition for treating cancer adapted for intra-tumoral administration and uses thereof
失效
用于治疗适于肿瘤内给药的癌症的组合物及其用途
- Patent Title: Composition for treating cancer adapted for intra-tumoral administration and uses thereof
- Patent Title (中): 用于治疗适于肿瘤内给药的癌症的组合物及其用途
-
Application No.: US11918533Application Date: 2006-04-14
-
Publication No.: US07888320B2Publication Date: 2011-02-15
- Inventor: Abdelilah Wakkach , Claudine Blin-Wakkach , David Momier , Georges Carle
- Applicant: Abdelilah Wakkach , Claudine Blin-Wakkach , David Momier , Georges Carle
- Applicant Address: FR
- Assignee: Centre National de la Recherche Scientifique - CNRS
- Current Assignee: Centre National de la Recherche Scientifique - CNRS
- Current Assignee Address: FR
- Agency: DLA Piper LLP (US)
- Priority: EP05290842 20050415
- International Application: PCT/IB2006/001418 WO 20060414
- International Announcement: WO2006/109188 WO 20061019
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K38/00 ; A61K48/00
Abstract:
A composition is adapted for intra-tumoral administration of a subject suffering from cancer, whereby administration of the composition to the subject induces IMC differentiation by neutralizing a factor implicated in a DC differentiation defect.
Public/Granted literature
- US20090148452A1 Composition for treating cancer adapted for intra-tumoral administration and uses thereof Public/Granted day:2009-06-11
Information query
